7Baggers

ImmunityBio Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 037.9275.84113.77151.69189.61227.53265.45Milllion

ImmunityBio Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 
                                           
  assets                                         
  current assets:                                         
  cash and cash equivalents137,658,000 60,660,000 143,428,000 111,966,000 130,104,000 133,035,000 265,453,000 177,963,000 43,506,000 88,481,000 104,641,000 104,161,000 61,900,000 36,385,000 181,101,000 64,524,000 83,958,000 44,679,000 11,441,000 27,688,000 102,698,000 16,952,000 15,508,000 18,291,000 17,279,000 22,279,000 16,821,000 15,310,000 16,122,000 11,196,000 23,872,000 20,920,000 39,039,000 13,596,000 8,083,000 31,404,000 38,223,000 63,250,000 175,908,000 358,616,000 120,437,000 
  marketable securities16,000,000 931,000 6,381,000 18,401,000 87,875,000 37,460,000 1,009,000 11,833,000 2,448,000 2,787,000 2,543,000 6,896,000 21,038,000 155,947,000 136,015,000 15,848,000 19,970,000 38,594,000             104,280,000 131,347,000 136,466,000 177,374,000 190,838,000 177,852,000 175,540,000 158,509,000 118,310,000   
  accounts receivable22,126,000 17,029,000 2,360,000 4,175,000 1,033,000                                    45,000 
  inventories6,640,000 8,444,000 8,272,000 1,958,000 1,811,000                                     
  due from related parties204,000 424,000 293,000 729,000 1,027,000 2,137,000 2,019,000 2,325,000 2,025,000 1,464,000 1,890,000 1,488,000 1,451,000 3,893,000 1,333,000 1,304,000 2,047,000 2,057,000        86,000 90,000 107,000 54,000 55,000 154,000 61,000 79,000 82,000 1,089,000       
  prepaid expenses and other current assets23,270,000 19,646,000 23,852,000 25,921,000 20,980,000 23,090,000 25,603,000 22,961,000 18,846,000 20,754,000 31,503,000 30,547,000 30,601,000 16,116,000 15,898,000 12,776,000 7,756,000 14,242,000 9,285,000 8,977,000 4,664,000 3,910,000 4,105,000 5,556,000 2,746,000 13,595,000 13,810,000 16,432,000 4,734,000 4,958,000 4,152,000 4,525,000 5,973,000 4,896,000 5,135,000 5,215,000  3,776,000  1,671,000 388,000 
  prepaid expenses – related parties2,234,000 2,029,000                                        
  total current assets208,132,000 109,163,000 184,586,000 163,150,000 242,830,000 195,722,000 294,084,000 215,082,000 66,825,000 113,486,000 140,577,000 143,092,000 114,990,000 212,341,000 334,347,000 94,452,000 113,731,000 99,572,000 75,498,000 98,018,000 115,287,000 44,125,000 55,757,000 71,613,000 87,048,000 113,430,000 88,772,000 100,570,000 110,093,000 126,802,000 132,458,000 156,853,000 181,557,000 195,948,000 205,145,000 214,471,000 217,959,000 225,535,000 297,540,000 360,287,000 120,870,000 
  property, plant and equipment133,004,000 135,270,000 137,094,000 139,285,000 141,956,000 143,517,000 146,082,000 152,000,000 151,487,000 154,165,000 143,659,000 130,441,000 119,445,000 105,217,000 82,863,000 69,878,000 89,023,000 80,875,000 53,927,000 55,864,000 58,615,000 58,539,000 60,501,000 62,157,000 65,089,000 67,921,000 76,885,000 77,273,000 78,211,000 76,826,000 76,726,000 74,471,000 60,218,000 22,558,000 18,906,000       
  goodwill and intangible assets14,977,000 15,443,000 15,933,000 16,479,000                                      
  convertible note receivable7,254,000 7,192,000 7,130,000 7,067,000 7,004,000 6,942,000 6,879,000 6,816,000 6,753,000 6,691,000 6,629,000 6,566,000 6,503,000 6,441,000 6,379,000 6,316,000 6,253,000 6,191,000                        
  operating lease right-of-use assets20,103,000 16,482,000 33,363,000 34,946,000 33,817,000 35,197,000 36,543,000 35,810,000 42,555,000 44,191,000 45,788,000 46,429,000 48,103,000 35,897,000 36,304,000 34,099,000 28,230,000 18,447,000 13,463,000 14,602,000 10,407,000 11,055,000 11,729,000 12,407,000 12,513,000 13,155,000                
  operating lease right-of-use assets, net – related parties14,620,000 15,298,000                                        
  other assets3,553,000 4,533,000 4,827,000 3,643,000 2,660,000 2,729,000 2,880,000 3,427,000 3,774,000 4,545,000  5,133,000 6,024,000 6,477,000  7,442,000 6,797,000 1,905,000 1,121,000 2,029,000 2,602,000 4,051,000 4,386,000 3,284,000 310,000 314,000 1,527,000 1,583,000 354,000 366,000 330,000 324,000 335,000 661,000 788,000 862,000 1,140,000 1,696,000 1,359,000 1,326,000 3,757,000 
  other assets – related parties433,000 378,000                                        
  total assets402,076,000 303,759,000 382,933,000 364,570,000 444,325,000 400,679,000 504,452,000 432,419,000 291,227,000 343,400,000 362,356,000 352,943,000 317,717,000 389,587,000 468,910,000 214,421,000 246,301,000 209,428,000 151,858,000 180,535,000 196,164,000 127,023,000 143,123,000 160,207,000 175,696,000 208,261,000 181,950,000 201,641,000 211,433,000 229,845,000 250,440,000 277,737,000 301,620,000 303,675,000 317,496,000 332,411,000 342,935,000 357,428,000 366,849,000 370,191,000 132,557,000 
  liabilities and stockholders’ deficit                                         
  current liabilities:                                         
  accounts payable7,419,000 13,501,000 6,725,000 9,945,000 20,317,000 13,869,000 9,195,000 19,818,000 25,488,000 33,573,000 21,016,000 20,237,000 18,053,000 9,832,000 11,418,000 15,120,000 19,153,000 20,097,000 4,101,000 6,160,000 3,971,000 3,148,000 1,749,000 2,115,000 1,927,000 2,804,000 2,793,000 3,525,000 5,502,000 3,566,000 5,865,000 9,485,000 4,271,000 4,280,000 4,045,000 2,245,000 3,303,000 1,105,000 2,085,000 4,947,000 3,180,000 
  accrued expenses and other liabilities35,705,000 27,889,000 40,580,000 43,596,000 35,344,000 32,712,000 42,708,000 64,871,000 62,335,000 54,118,000 41,825,000 46,220,000 52,351,000 62,468,000 51,387,000 38,519,000 36,134,000 36,793,000                        
  operating lease liabilities3,682,000 3,876,000 7,466,000 7,033,000 6,249,000 6,082,000 5,244,000 4,363,000 5,984,000 2,844,000 2,650,000 1,365,000 1,404,000 3,507,000 3,011,000 3,072,000 2,430,000 5,156,000 5,500,000 5,351,000                      
  operating lease liabilities – related parties3,710,000 3,584,000                                        
  due to related parties128,000 355,000 173,000 386,000 200,000 1,096,000 1,136,000 1,272,000 1,159,000 2,932,000 3,469,000 3,018,000 4,158,000 5,595,000 3,943,000 8,697,000 16,711,000 17,817,000 5,269,000 1,356,000 2,228,000 853,000 486,000 868,000 957,000 1,531,000 1,696,000 2,175,000 1,806,000 2,456,000 2,363,000 1,986,000 2,216,000 2,124,000 1,753,000 1,853,000 1,727,000 1,674,000 1,352,000 610,000  
  total current liabilities50,644,000 49,205,000 54,944,000 60,960,000 62,110,000 53,759,000 58,283,000 90,324,000 613,478,000 564,945,000 500,861,000 70,840,000 376,050,000 381,014,000 368,995,000 65,408,000 74,428,000 79,863,000 24,651,000 20,663,000 17,049,000 14,248,000 11,559,000 12,519,000 12,430,000 27,701,000 27,260,000 30,404,000 20,192,000 19,398,000 20,868,000 28,674,000 36,878,000 14,201,000 12,553,000 10,232,000 10,045,000 7,858,000 6,148,000 6,683,000  
  related-party convertible note payable, at fair value492,084,000 485,717,000 461,877,000                                       
  revenue interest liability307,049,000 296,287,000 284,404,000 273,657,000 263,342,000 163,416,000 155,415,000                                   
  operating lease liabilities, less current portion20,798,000 17,077,000 34,823,000 36,761,000 36,427,000 38,199,000 39,942,000 39,313,000 44,558,000 46,289,000 47,951,000 49,561,000 50,648,000 36,251,000 37,068,000 34,642,000 29,116,000 16,554,000 9,814,000 11,250,000                      
  operating lease liabilities, less current portion – related parties15,042,000 16,020,000                                        
  derivative liabilities18,611,000 20,542,000 25,800,000 19,223,000 20,807,000 37,930,000 35,333,000                                   
  warrant liabilities66,957,000 9,023,000 8,575,000 18,308,000 65,395,000 109,987,000 118,770,000 39,370,000 27,799,000 17,780,000                                
  other liabilities710,000 370,000 639,000 705,000 704,000 1,285,000 1,109,000 467,000 473,000 462,000 457,000 569,000 290,000 288,000 249,000 905,000 920,000 891,000          24,000 44,000 65,000 89,000 341,000 370,000 216,000 240,000 22,000 26,000     
  total liabilities971,895,000 894,241,000 871,062,000 1,108,732,000 1,141,703,000 1,091,662,000 1,090,389,000 843,064,000 936,410,000 875,116,000 812,176,000 782,024,000 739,691,000 727,143,000 712,823,000 404,365,000 404,886,000 394,764,000 34,465,000 31,913,000 26,511,000 24,428,000 22,444,000 24,251,000 24,427,000 40,453,000 35,944,000 39,555,000 29,802,000 29,485,000 31,596,000 40,033,000 48,696,000 25,306,000 24,078,000 21,520,000 15,578,000 12,928,000 10,854,000 7,260,000 6,039,000 
  commitments and contingencies                                         
  stockholders’ deficit:                                         
  common stock91,000 85,000 85,000 70,000 69,000 68,000 67,000 67,000 44,000 43,000 42,000 40,000 40,000 40,000 40,000 39,000 39,000 38,000 11,000 11,000 11,000 10,000 10,000 10,000 10,000 10,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 7,000 
  additional paid-in capital3,014,041,000 2,893,422,000 2,884,867,000 2,570,765,000 2,531,909,000 2,403,720,000 2,374,620,000 2,315,716,000 1,990,590,000 1,965,838,000 1,930,936,000 1,843,724,000 1,739,590,000 1,729,430,000 1,719,704,000 1,682,072,000 1,625,018,000 1,508,958,000 872,078,000 871,170,000 870,408,000 783,287,000 782,965,000 782,549,000 782,312,000 781,790,000 741,246,000 739,839,000 735,849,000 726,953,000 717,930,000 709,353,000 700,639,000 691,229,000 680,757,000 669,624,000 651,330,000 625,200,000 606,555,000 535,696,000 256,515,000 
  accumulated deficit-3,597,449,000 -3,504,894,000 -3,375,248,000 -3,316,086,000 -3,230,357,000 -3,095,793,000 -2,961,684,000 -2,728,292,000 -2,632,710,000 -2,494,831,000 -2,378,488,000 -2,270,273,000 -2,159,335,000 -2,064,747,000 -1,961,921,000 -1,870,662,000 -1,783,033,000 -1,694,745,000 -754,574,000 -722,442,000 -700,666,000 -680,574,000 -662,191,000 -646,550,000 -630,969,000 -613,786,000 -594,981,000 -577,413,000 -553,778,000 -526,046,000 -498,713,000 -471,455,000 -447,486,000 -412,628,000 -387,063,000 -358,876,000 -324,405,000 -281,026,000 -250,376,000 -172,723,000 -130,004,000 
  accumulated other comprehensive income12,568,000 19,956,000 1,198,000 103,000 -8,000 -7,000 10,000 792,000 -40,000 -33,000 183,000 -190,000 -110,000 -367,000 4,000 53,000 37,000 -38,000                  135,000 424,000 318,000    
  total immunitybio stockholders’ deficit-570,749,000 -591,431,000 -489,098,000 -745,148,000 -698,387,000 -692,012,000 -586,987,000 -411,717,000 -642,116,000 -528,983,000 -447,327,000 -426,699,000 -419,815,000 -335,644,000 -242,173,000 -188,498,000 -157,939,000 -185,787,000                        
  noncontrolling interests930,000 949,000 969,000 986,000 1,009,000 1,029,000 1,050,000 1,072,000 -3,067,000 -2,733,000 -2,493,000 -2,382,000 -2,159,000 -1,912,000 -1,740,000 -1,446,000 -646,000 451,000                        
  total stockholders’ deficit-569,819,000 -590,482,000 -488,129,000 -744,162,000 -697,378,000 -690,983,000 -585,937,000 -410,645,000 -645,183,000 -531,716,000 -449,820,000 -429,081,000 -421,974,000 -337,556,000 -243,913,000 -189,944,000 -158,585,000 -185,336,000                        
  total liabilities and stockholders’ deficit402,076,000 303,759,000 382,933,000 364,570,000 444,325,000 400,679,000 504,452,000 432,419,000 291,227,000 343,400,000 362,356,000 352,943,000 317,717,000 389,587,000 468,910,000 214,421,000 246,301,000 209,428,000                        
  marketable securities, noncurrent      891,000 817,000 841,000 820,000 840,000 811,000 914,000 865,000 822,000 802,000 822,000 1,000,000             29,600,000 34,198,000 47,054,000 71,487,000 87,571,000 94,655,000 107,933,000 116,197,000 55,135,000   
  related-party nonconvertible note, net of discount   111,143,000 108,811,000 106,637,000 104,586,000                                   
  related-party convertible notes and accrued interest, net of discount   587,975,000 584,107,000 580,449,000 576,951,000 165,289,000 250,102,000 245,640,000                                
  intangible assets    16,058,000 16,572,000 17,093,000 18,467,000 18,992,000 19,502,000  20,471,000 21,738,000 22,349,000             565,000 1,130,000 1,695,000 2,260,000 2,826,000 3,391,000 3,956,000 4,521,000 5,086,000 5,948,000 6,396,000 6,844,000 7,292,000 7,164,000 7,620,000 
  related-party promissory notes, net of discounts and deferred issuance costs        481,894,000 441,628,000 431,901,000                               
  related-party promissory notes, less current portion       480,020,000     312,541,000 309,428,000                            
  related-party convertible note payable at fair value       28,281,000                                  
  related-party convertible note at fair value        36,618,000 29,850,000                                
  intangible asset          20,003,000    1,420,000 1,432,000 1,445,000 1,438,000                        
  investment and other assets          4,860,000    6,775,000                           
  related-party convertible notes and accrued interest, net of discount, less current portion          241,271,000 287,761,000                              
  warrant liability          21,636,000                               
  related-party promissory note, net of deferred issuance costs                                         
  related-party promissory notes, net of discount, less current portion           373,293,000                              
  related-party promissory notes, current portion            300,084,000 299,612,000                            
  deferred income tax liability            162,000 162,000  170,000 170,000 170,000                        
  non-marketable equity investment                                         
  related-party notes payable              299,236,000 303,240,000 300,252,000 297,286,000                        
  related-party notes payable, less current portion              306,349,000                           
  deferred tax liability              162,000             122,000 250,000 374,000 498,000 681,000 779,000 903,000 996,000 883,000 969,000 1,072,000 1,165,000   
  marketable debt securities, available-for-sale                  54,772,000 61,353,000 7,925,000 23,263,000 36,144,000 47,766,000 66,773,000 76,270,000 57,328,000 67,998,000 88,822,000             
  marketable debt securities, noncurrent                   769,000   1,497,000 1,493,000 1,483,000 4,190,000 5,701,000 12,585,000 12,580,000 15,091,000            
  equity investment                  7,849,000 9,253,000 9,253,000 9,253,000 9,253,000     8,500,000 8,500,000 8,500,000            
  liabilities and stockholders’ equity                                         
  accrued expenses                  8,343,000 5,497,000 7,449,000 6,634,000 5,343,000 5,251,000 6,466,000 20,242,000 21,104,000 22,785,000 11,517,000 12,077,000 11,267,000 15,838,000 14,381,000 6,858,000 5,864,000 5,910,000 4,724,000 4,716,000 2,575,000 1,126,000 2,618,000 
  other current liabilities                  1,438,000 2,299,000 3,401,000 3,613,000 3,981,000 4,285,000 3,080,000 3,124,000 1,667,000 1,919,000 1,367,000 1,299,000 1,373,000 1,365,000 1,130,000 939,000 891,000 224,000 291,000 363,000 136,000   
  stockholders’ equity:                                         
  accumulated other comprehensive loss                  -122,000 -117,000 -100,000 -128,000 -105,000 -53,000 -84,000 -206,000 -267,000 -348,000 -448,000 -555,000 -381,000 -202,000 -237,000 -240,000 -284,000    -192,000 -50,000  
  total stockholders’ equity                  117,393,000 148,622,000 169,653,000 102,595,000 120,679,000 135,956,000 151,269,000 167,808,000 146,006,000 162,086,000 181,631,000 200,360,000 218,844,000 237,704,000 252,924,000 278,369,000 293,418,000 310,891,000 327,357,000 344,500,000 355,995,000 362,931,000 126,518,000 
  total liabilities and stockholders’ equity                  151,858,000 180,535,000 196,164,000 127,023,000 143,123,000 160,207,000 175,696,000 208,261,000 181,950,000 201,641,000 211,433,000 229,845,000 250,440,000 277,737,000 301,620,000 303,675,000 317,496,000 332,411,000 342,935,000 357,428,000 366,849,000 370,191,000 132,557,000 
  operating lease liability, less current portion                    9,462,000 10,180,000 10,885,000 11,732,000 11,997,000 12,752,000                
  notes receivable, held-to-maturity                          723,000 723,000              
  financing obligation, less current portion                          5,945,000 6,108,000 6,267,000 1,663,000 1,741,000 1,814,000 1,885,000 1,955,000 2,025,000 2,390,000      
  deferred rent                          2,739,000 2,897,000 3,049,000 3,188,000 3,325,000 3,461,000 3,595,000 2,374,000 2,426,000 2,488,000 1,924,000 1,344,000 845,000 342,000  
  investment in equity securities                       9,253,000 9,253,000 9,251,000 8,500,000               
  restricted cash                        250,000 1,200,000                
  stockholders’ equity                                         
  build-to-suit liability, less current portion                             4,797,000 4,909,000 5,062,000 5,189,000 5,475,000 5,651,000 5,313,000 2,417,000 2,451,000    
  note receivable, held-to-maturity                            361,000             
  marketable debt securities                             110,593,000            
  cost method investment                              8,500,000 8,500,000 8,500,000 8,500,000        
  deferred revenue                              166,000   182,000 187,000 192,000 197,000 203,000 228,000 235,000 241,000 
  financing obligation                                14,880,000         
  property and equipment                                   16,475,000 9,507,000 7,156,000 5,523,000 1,414,000 310,000 
  receivables, net, prepaid expenses and other current assets                                    4,196,000  3,322,000   
  liabilities and stockholders' equity                                         
  build-to-suit lease liability, less current portion                                      2,468,000   
  stockholders' equity                                         
  class a common stock                                         
  investment in inex bio, inc.                                         
  notes payable                                         
  warrant derivative liability                                         

We provide you with 20 years of balance sheets for ImmunityBio stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ImmunityBio. Explore the full financial landscape of ImmunityBio stock with our expertly curated balance sheets.

The information provided in this report about ImmunityBio stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.